Kyle Malady - 22 Jun 2023 Form 4 Insider Report for VERIZON COMMUNICATIONS INC (VZ)

Reporting relationship: EVP and Group CEO-VZ Business
Issuer ticker: VZ
Reported as of: 22 Jun 2023
Net transaction value: +$1,546
SEC form: 4
Accepted by SEC: 26 Jun 2023, 07:32:53 UTC
Prior SEC filing: 12 Jun 2023
Next SEC filing: 10 Jul 2023
Source filing: View source filing
Reporting owner signature: Brandon N. Egren, Attorney-in-fact for Kyle Malady

Key filing fact

Kyle Malady filed Form 4 for VERIZON COMMUNICATIONS INC (VZ) on 26 Jun 2023.

Key facts

This page summarizes Kyle Malady's Form 4 filing for VERIZON COMMUNICATIONS INC (VZ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Jun 2023, 07:32.

Change

Previous filing in this sequence was filed on 12 Jun 2023.
Current net transaction value: +$1,546.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VZ transaction Derivative

Phantom Stock (unitized)

Award

Transaction value: $1,546
Shares: +151
Change %: +0.13%
Price: $10.24
Shares after: 114,992
Date: 22 Jun 2023
Ownership: By Deferred Compensation Plan
Underlying class: Common Stock
Underlying amount: 43
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.

Footnote F2

Includes phantom stock acquired through dividend reinvestment.